Base period - preventive maintenance for one (1) BD lsrfortessa 3 laser system (serial #H5B300008) equipped with BD high throughput sampler (HTS) and one additional laser (Y/G).
Ended Awarded Last action
- Contract number
- 75N91023F00108
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $52,943
Award facts
- Opportunity
-
- 440070709 Solicitation number
- Contract value 40% obligated
-
- $52,943.04 Current, with exercised options
- $132,357.60 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95131, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Exercise an Option | $26,472 | |
| Original award | $26,472 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Becton, Dickinson and Company (BD). The contract is for preventive maintenance services on a BD LSRFortessa 3 laser flow cytometry system with a high-throughput sampler and an additional laser. The contract has a base period of performance from July 1, 2023, through June 30, 2025, with a ceiling value of $132,357.60. This contract is not associated with a set-aside program and was competed openly. BD is a large, established medical technology manufacturer that has a significant portfolio of federal contract awards, primarily focused on flow cytometry instruments, maintenance services, and related consumables for government research and healthcare institutions.
Quick answers
Who was awarded contract 75N91023F00108?
75N91023F00108 was awarded to Becton, Dickinson And Company by National Cancer Institute (National Institutes of Health) on July 1, 2023.
How much is contract 75N91023F00108 worth?
The government has obligated $52,943 on 75N91023F00108. Its potential value, with all options, is $132,358.
Is contract 75N91023F00108 an order under another contract?
Yes. 75N91023F00108 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N91023F00108 competed?
The extent of competition for 75N91023F00108 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award